Silva Paul M bought RAPP
October 22, 2026 · Form 4 insider transaction
Silva Paul M bought 3,680 shares of Rapport Therapeutics, Inc. at $27.07 per share, a transaction worth $99.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,680
Price
$27.07
Total value
$99.6K
InsiderSilva Paul M
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateOctober 22, 2026
Filing dateOctober 22, 2026
Shares owned after3,680
OwnershipIndirect
10b5-1 planNo
AmendedNo